Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1975 1
1980 1
1981 1
1982 1
1984 1
1985 7
1986 2
1987 2
1988 1
1990 7
1991 6
1992 2
1993 3
1994 5
1995 3
1996 5
1997 6
1998 6
1999 4
2000 6
2001 9
2002 3
2003 4
2004 7
2005 11
2006 6
2007 7
2008 8
2009 3
2010 6
2011 12
2012 12
2013 11
2014 13
2015 10
2016 11
2017 13
2018 23
2019 27
2020 14
2021 12
2022 9
2023 6
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

281 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Functioning Lung Carcinoid Tumor"
Page 1
T-Cell-Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028.
Ott PA, Bang YJ, Piha-Paul SA, Razak ARA, Bennouna J, Soria JC, Rugo HS, Cohen RB, O'Neil BH, Mehnert JM, Lopez J, Doi T, van Brummelen EMJ, Cristescu R, Yang P, Emancipator K, Stein K, Ayers M, Joe AK, Lunceford JK. Ott PA, et al. J Clin Oncol. 2019 Feb 1;37(4):318-327. doi: 10.1200/JCO.2018.78.2276. Epub 2018 Dec 13. J Clin Oncol. 2019. PMID: 30557521 Clinical Trial.
PURPOSE: Biomarkers that can predict response to anti-programmed cell death 1 (PD-1) therapy across multiple tumor types include a T-cell-inflamed gene-expression profile (GEP), programmed death ligand 1 (PD-L1) expression, and tumor mutational burden (TMB). ...RESU …
PURPOSE: Biomarkers that can predict response to anti-programmed cell death 1 (PD-1) therapy across multiple tumor types include a T- …
Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors.
Ito T, Igarashi H, Uehara H, Berna MJ, Jensen RT. Ito T, et al. Medicine (Baltimore). 2013 May;92(3):135-181. doi: 10.1097/MD.0b013e3182954af1. Medicine (Baltimore). 2013. PMID: 23645327 Free PMC article.
Multiple endocrine neoplasia type 1 (MEN1) is classically characterized by the development of functional or nonfunctional hyperplasia or tumors in endocrine tissues (parathyroid, pancreas, pituitary, adrenal). ...The causes of non-MEN1-related death for the 2 series, in de …
Multiple endocrine neoplasia type 1 (MEN1) is classically characterized by the development of functional or nonfunctional hyperplasia …
Small-Cell Carcinoma of the Lung: What We Learned about It?
Righi L, Volante M, Papotti M. Righi L, et al. Acta Cytol. 2022;66(4):257-268. doi: 10.1159/000519688. Epub 2021 Nov 16. Acta Cytol. 2022. PMID: 34784591 Review.
Small-cell lung carcinoma (SCLC) is a high-grade aggressive disease that belongs to the neuroendocrine (NE) group of lung tumors that also includes typical carcinoid, atypical carcinoid, and large-cell NE carcinoma. ...
Small-cell lung carcinoma (SCLC) is a high-grade aggressive disease that belongs to the neuroendocrine (NE) group of lung tumo …
Characterization, Prognosis, and Treatment of Patients With Metastatic Lung Carcinoid Tumors.
Robelin P, Hadoux J, Forestier J, Planchard D, Hervieu V, Berdelou A, Scoazec JY, Valette PJ, Leboulleux S, Ducreux M, Lombard-Bohas C, Baudin E, Walter T. Robelin P, et al. J Thorac Oncol. 2019 Jun;14(6):993-1002. doi: 10.1016/j.jtho.2019.02.002. Epub 2019 Feb 13. J Thorac Oncol. 2019. PMID: 30771520 Free article. Review.
INTRODUCTION: Metastatic lung carcinoids (MLCs) remain poorly characterized and no prognostic stratification exists. ...A functioning syndrome was observed in 43% of cases and an uptake at somatostatin receptor scintigraphy in 76% of cases. ...
INTRODUCTION: Metastatic lung carcinoids (MLCs) remain poorly characterized and no prognostic stratification exists. ...A function …
Morphologic and molecular classification of lung neuroendocrine neoplasms.
Metovic J, Barella M, Bianchi F, Hofman P, Hofman V, Remmelink M, Kern I, Carvalho L, Pattini L, Sonzogni A, Veronesi G, Harari S, Forest F, Papotti M, Pelosi G. Metovic J, et al. Virchows Arch. 2021 Jan;478(1):5-19. doi: 10.1007/s00428-020-03015-z. Epub 2021 Jan 21. Virchows Arch. 2021. PMID: 33474631 Free PMC article. Review.
Neuroendocrine neoplasms (NENs) of the lung encompass neuroendocrine tumors (NETs) composed of typical (TC) and atypical (AC) carcinoids and full-fledged carcinomas (NECs) inclusive of large cell neuroendocrine carcinoma (LCNEC) and small cell carcinoma (SCLC). ...We herei …
Neuroendocrine neoplasms (NENs) of the lung encompass neuroendocrine tumors (NETs) composed of typical (TC) and atypical (AC) carcino …
Recent advances and current controversies in lung neuroendocrine neoplasms().
Metovic J, Bianchi F, Rossi G, Barella M, Sonzogni A, Harari S, Papotti M, Pelosi G. Metovic J, et al. Semin Diagn Pathol. 2021 Sep;38(5):90-97. doi: 10.1053/j.semdp.2021.03.002. Epub 2021 Mar 19. Semin Diagn Pathol. 2021. PMID: 33810912 Review.
In the lung, neuroendocrine tumors (NETs), namely typical and atypical carcinoids, and neuroendocrine carcinomas (NECs), grouping small cell carcinoma (SCLC) and large cell neuroendocrine carcinoma (LCNEC), make up for distinct tumor entities according to epidemiolo …
In the lung, neuroendocrine tumors (NETs), namely typical and atypical carcinoids, and neuroendocrine carcinomas (NECs), grouping sma …
Cutaneous manifestations of lung cancer.
Owen CE. Owen CE. Semin Oncol. 2016 Jun;43(3):366-9. doi: 10.1053/j.seminoncol.2016.02.025. Epub 2016 Feb 23. Semin Oncol. 2016. PMID: 27178690 Review.
Malignancy-associated dermatoses comprise a broad group of hyperproliferative and inflammatory disorders, disorders caused by tumor production of hormonal or metabolic factors, autoimmune connective tissue diseases, among others. In this review, paraneoplastic syndromes as …
Malignancy-associated dermatoses comprise a broad group of hyperproliferative and inflammatory disorders, disorders caused by tumor p …
Thymectomy and malignancy.
Masaoka A, Yamakawa Y, Niwa H, Fukai I, Saito Y, Tokudome S, Nakahara K, Fujii Y. Masaoka A, et al. Eur J Cardiothorac Surg. 1994;8(5):251-3. doi: 10.1016/1010-7940(94)90155-4. Eur J Cardiothorac Surg. 1994. PMID: 8043287 Review.
Malignant neoplasms were detected in ten patients, four of whom already had the tumor at the time MG was diagnosed. Thus, malignancy developed after thymectomy in six patients. Malignant fibrous histiocytoma (MFH) developed in three patients, as well as gastric cancer, gas …
Malignant neoplasms were detected in ten patients, four of whom already had the tumor at the time MG was diagnosed. Thus, malignancy …
Feasibility of shape-sensing robotic-assisted bronchoscopy for biomarker identification in patients with thoracic malignancies.
Connolly JG, Kalchiem-Dekel O, Tan KS, Dycoco J, Chawla M, Rocco G, Park BJ, Lee RP, Beattie JA, Solomon SB, Ziv E, Adusumilli PS, Buonocore DJ, Husta BC, Jones DR, Baine MK, Bott MJ. Connolly JG, et al. J Thorac Cardiovasc Surg. 2023 Jul;166(1):231-240.e2. doi: 10.1016/j.jtcvs.2022.10.059. Epub 2022 Nov 25. J Thorac Cardiovasc Surg. 2023. PMID: 36621452
Univariable and multivariable linear regression models were constructed to assess associations between lesion- and procedure-related variables and tumor cellularity. RESULTS: In total, 128 samples were analyzed: 104 primary lung cancers and 24 metastatic lesions. .. …
Univariable and multivariable linear regression models were constructed to assess associations between lesion- and procedure-related variabl …
Paraneoplastic neurologic manifestations of neuroendocrine tumors.
Zoccarato M, Grisold W. Zoccarato M, et al. Handb Clin Neurol. 2024;200:397-407. doi: 10.1016/B978-0-12-823912-4.00023-2. Handb Clin Neurol. 2024. PMID: 38494292 Review.
Neurologic involvement is determined by the rare development of paraneoplastic syndromes, which are remote effects of cancer. Mechanisms depend on immunologic response to a tumor, leading to the immune attack on the nervous system or the production of biologically active ( …
Neurologic involvement is determined by the rare development of paraneoplastic syndromes, which are remote effects of cancer. Mechanisms dep …
281 results